The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K–AKT signaling pathway

被引：0
|
作者：
Lan Zhang
Shanfeng Lin
Zeying Zhang
Cong Yan
Fayu Liu
机构：
[1] China Medical University,Department of Oromaxillofacial
[2] Liaoning Provincial Key Laboratory of Oral Disease,Head and Neck Surgery, School and Hospital of Stomatology
[3] China Medical University,Nosocomial Infection Management Office, School and Hospital of Stomatology
[4] Liaoning Provincial Key Laboratory of Oral Diseases,Department of Endodontics, School and Hospital of Stomatology
[5] China Medical University,undefined
[6] Liaoning Provincial Key Laboratory of Oral Disease,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Oral squamous carcinoma; PAK4; P21-activated kinase 4; PI3K–AKT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：739 / 747
页数：8
相关论文
共 50 条
  • [31] As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma
    Liu, Shanshan
    Gao, Wenzhen
    Lu, Yupu
    Zhou, Qin
    Su, Rongjian
    Hasegawa, Tomoka
    Du, Juan
    Li, Minqi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 491 - 506
  • [32] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [33] IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway
    Liu, Peng
    Kong, Xin
    Yi, Shijiang
    Chen, Ying
    Luo, Wenlong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [34] IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway
    Peng Liu
    Xin Kong
    Shijiang Yi
    Ying Chen
    Wenlong Luo
    World Journal of Surgical Oncology, 22
  • [35] Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
    Singh, Shikha Satendra
    Yap, Wei Ney
    Arfuso, Frank
    Kar, Shreya
    Wang, Chao
    Cai, Wanpei
    Dharmarajan, Arunasalam M.
    Sethi, Gautam
    Kumar, Alan Prem
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (43) : 12261 - 12273
  • [36] Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
    Shikha Satendra Singh
    Wei Ney Yap
    Frank Arfuso
    Shreya Kar
    Chao Wang
    Wanpei Cai
    Arunasalam M Dharmarajan
    Gautam Sethi
    Alan Prem Kumar
    World Journal of Gastroenterology, 2015, 21 (43) : 12261 - 12273
  • [37] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [38] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)
  • [39] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [40] PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
    Luo, Qian
    Du, Ruijuan
    Liu, Wenting
    Huang, Guojing
    Dong, Zigang
    Li, Xiang
    FRONTIERS IN ONCOLOGY, 2022, 12
12345